Emmaus Life Sciences Inc (EMMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 3,852 | 3,378 | 2,817 | 2,406 | 3,292 |
| Cost of Goods | 235 | 247 | 150 | 225 | 309 |
| Gross Profit | 3,617 | 3,131 | 2,667 | 2,181 | 2,983 |
| Operating Expenses | 2,966 | 2,683 | 3,187 | 3,386 | 3,849 |
| Operating Income | 886 | 695 | -370 | -980 | -557 |
| Interest Expense | 2,269 | 1,931 | 1,678 | 1,256 | 1,278 |
| Other Income | -552 | -261 | 323 | -90 | 93 |
| Pre-tax Income | -1,935 | -1,497 | -1,725 | -2,326 | -1,742 |
| Income Tax | 16 | 579 | -590 | 4 | 6 |
| Net Income Continuous | -1,951 | -2,076 | -1,135 | -2,330 | -1,748 |
| Net Income | $-1,951 | $-2,076 | $-1,135 | $-2,330 | $-1,748 |
| EPS Basic Total Ops | -0.03 | -0.03 | -0.02 | -0.04 | -0.03 |
| EPS Basic Continuous Ops | -0.03 | -0.03 | -0.02 | -0.04 | -0.03 |
| EPS Diluted Total Ops | -0.03 | -0.03 | -0.02 | -0.04 | -0.03 |
| EPS Diluted Continuous Ops | -0.03 | -0.03 | -0.02 | -0.04 | -0.03 |
| EPS Diluted Before Non-Recurring Items | -0.03 | -0.03 | -0.02 | -0.04 | -0.03 |
| EBITDA(a) | $1,092 | $852 | $-238 | $-876 | $-476 |